Cargando…
Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Pathologists of Australasia. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355740/ https://www.ncbi.nlm.nih.gov/pubmed/35989103 http://dx.doi.org/10.1016/j.pathol.2022.07.002 |
_version_ | 1784763363548463104 |
---|---|
author | Abasszade, Joshua Haron La, Paul Bao Duy Shelmerdine, Emily Nalpantidis, Anastasios Curtin, Natasha Grigoriadis, George Fedele, Pasquale Luke |
author_facet | Abasszade, Joshua Haron La, Paul Bao Duy Shelmerdine, Emily Nalpantidis, Anastasios Curtin, Natasha Grigoriadis, George Fedele, Pasquale Luke |
author_sort | Abasszade, Joshua Haron |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9355740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Royal College of Pathologists of Australasia. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93557402022-08-07 Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series Abasszade, Joshua Haron La, Paul Bao Duy Shelmerdine, Emily Nalpantidis, Anastasios Curtin, Natasha Grigoriadis, George Fedele, Pasquale Luke Pathology Correspondence Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022-10 2022-08-06 /pmc/articles/PMC9355740/ /pubmed/35989103 http://dx.doi.org/10.1016/j.pathol.2022.07.002 Text en © 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Abasszade, Joshua Haron La, Paul Bao Duy Shelmerdine, Emily Nalpantidis, Anastasios Curtin, Natasha Grigoriadis, George Fedele, Pasquale Luke Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
title | Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
title_full | Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
title_fullStr | Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
title_full_unstemmed | Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
title_short | Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
title_sort | severe autoimmune haemolytic anaemia following sars-cov-2 vaccination in patients with treatment naïve b-cell neoplasms: a case series |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355740/ https://www.ncbi.nlm.nih.gov/pubmed/35989103 http://dx.doi.org/10.1016/j.pathol.2022.07.002 |
work_keys_str_mv | AT abasszadejoshuaharon severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries AT lapaulbaoduy severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries AT shelmerdineemily severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries AT nalpantidisanastasios severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries AT curtinnatasha severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries AT grigoriadisgeorge severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries AT fedelepasqualeluke severeautoimmunehaemolyticanaemiafollowingsarscov2vaccinationinpatientswithtreatmentnaivebcellneoplasmsacaseseries |